Non-redundant functions of type 3 innate lymphoid cells in mucosal immunity

3型先天淋巴细胞在粘膜免疫中的非冗余功能

基本信息

项目摘要

Type 3 innate lymphoid cells (ILC3) perform multiple functions in host physiology. However, most of these functions have been elucidated in the context of T cell depletion. There is an extensive overlap of regulatory and functional networks between ILC3 and Th17 cells and how these two cell types contribute to immunity is unclear. Identification of non-redundant functions of ILC3 has been impeded by the lack of ILC3 depletion models that preserve normal T cell development and differentiation. To address this gap in knowledge, we created the first model in which ILC3 development is prevented, but B and T cell development and T cell differentiation is normal. Using this model we demonstrate a non-redundant function of ILC3 in mucosal protection against an intestinal pathogen. We will examine the specific mechanism of this protection, as well as identify novel T cell-independent functions of ILC3. Moreover, we will uncouple the role of LTi in lymph node and Peyer’s patch development from the role of adult lamina propria ILC3. We will also investigate the role of ILC3 in regulating homeostasis with the intestinal microbiota. Overall, our studies will elucidate the cellular and molecular mechanisms controlling non-redundant ILC3 functions in both maintaining a healthy gut and regulating infectious intestinal inflammation. We expect the results to lead to the development of more specific strategies for targeting ILC3 and Th17 cells to improve intestinal immune dysbalance or prevent pathologic intestinal inflammation.
3 型先天淋巴细胞 (ILC3) 在宿主生理学中发挥多种功能。然而,这些大多数 T 细胞耗竭的背景下已阐明其功能。监管存在广泛重叠 ILC3 和 Th17 细胞之间的功能网络以及这两种细胞类型如何促进免疫 尚不清楚。由于 ILC3 缺乏,ILC3 非冗余功能的鉴定受到阻碍 保留正常 T 细胞发育和分化的模型。为了解决这一知识差距,我们 创建了第一个模型,其中 ILC3 发育被阻止,但 B 细胞和 T 细胞发育以及 T 细胞 分化是正常的。使用该模型,我们证明了 ILC3 在粘膜中的非冗余功能 预防肠道病原体。我们将研究这种保护的具体机制,如 以及鉴定 ILC3 的新的独立于 T 细胞的功能。此外,我们将解开 LTi 的角色 淋巴结和派尔氏集结的发育来自成人固有层 ILC3 的作用。我们还将 研究 ILC3 在调节肠道菌群稳态中的作用。总的来说,我们的研究 将阐明控制非冗余 ILC3 功能的细胞和分子机制 维持健康的肠道并调节感染性肠道炎症。我们预计结果将领先 开发针对 ILC3 和 Th17 细胞的更具体策略,以改善肠道 免疫失调或预防病理性肠道炎症。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ivaylo Ivanov Ivanov其他文献

Ivaylo Ivanov Ivanov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ivaylo Ivanov Ivanov', 18)}}的其他基金

Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
  • 批准号:
    10621283
  • 财政年份:
    2021
  • 资助金额:
    $ 48.3万
  • 项目类别:
Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
  • 批准号:
    10282976
  • 财政年份:
    2021
  • 资助金额:
    $ 48.3万
  • 项目类别:
Maintenance of mucosal homeostasis by commensal Th17 cells
共生 Th17 细胞维持粘膜稳态
  • 批准号:
    10462753
  • 财政年份:
    2021
  • 资助金额:
    $ 48.3万
  • 项目类别:
Non-redundant functions of type 3 innate lymphoid cells in mucosal immunity
3型先天淋巴细胞在粘膜免疫中的非冗余功能
  • 批准号:
    9902326
  • 财政年份:
    2019
  • 资助金额:
    $ 48.3万
  • 项目类别:
Discovery of immunomodulatory gut microbes with MAGIC
利用 MAGIC 发现免疫调节肠道微生物
  • 批准号:
    9808632
  • 财政年份:
    2019
  • 资助金额:
    $ 48.3万
  • 项目类别:
New mechanism of commensal bacteria interaction with host immunity
共生菌与宿主免疫相互作用的新机制
  • 批准号:
    9317868
  • 财政年份:
    2017
  • 资助金额:
    $ 48.3万
  • 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
  • 批准号:
    8819130
  • 财政年份:
    2013
  • 资助金额:
    $ 48.3万
  • 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
  • 批准号:
    10475627
  • 财政年份:
    2013
  • 资助金额:
    $ 48.3万
  • 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
  • 批准号:
    8650824
  • 财政年份:
    2013
  • 资助金额:
    $ 48.3万
  • 项目类别:
Mechanisms of Mucosal Th17 Cell Induction By Segmented Filamentous Bacteria
分节丝状细菌诱导粘膜 Th17 细胞的机制
  • 批准号:
    9244017
  • 财政年份:
    2013
  • 资助金额:
    $ 48.3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了